Dr. Dickersin's major research interests are related to randomized clinical trials, trials registers, systematic reviews and meta analysis, publication bias, peer review, and evidence-basedhealthcare. She has conducted studies in a number of important subject areas, including women's health, eyes and vision, and surgery.

Dr. Dickersin serves as the Director for the Center for Clinical Trials, whose faculty, staff and students are involved in methodoloigic research, and oversee coordination of data collection and analysis of important clinical trials.

She is also Director of the US Cochrane Center, one of 12 Centers worldwide participating in The Cochrane Collaboration. The Collaboration aims to help people make well informed decisions about health by preparing, maintaining, and promoting the accessibility of systematic reviews of available evidence on the benefits and risks of health care. Dr. Dickersin also serves as an editor of the Eyes and Vision Review Group. In this regard, she oversees efforts in the United States to coordinate and contribute to the Cochrane Eyes and Vision Review Group (CEVG) (www.cochraneeyes.org).

clinical trials, systematic reviews and meta-analysis, evidence-based health care, publication bias, trials registration, peer review, eyes and vision, women's health, the Cochrane Collaboration

1993 - 1997 Frohlich Fellowship, New York Academy of Sciences. 1994 “Woman of Excellence,” National Association of Women Business Owners, Baltimore Regional Chapter.

1995 Ellen Barnett Memorial Award, Susan B. Komen Foundation Race for the Cure.

1996 Women’s Hall of Fame, Baltimore City Commission for Women.

1998; 2006 “Maryland’s Top 100 Women,” Daily Record.

1998 MAMM magazine’s “50 Who Made a Difference.”

1999 Elected to membership, American Epidemiological Society.

2000 “Exceptional Advocate,” National Breast Cancer Coalition.

1. Krieger N, Lowy I, Aronowitz R, Bigby J, Dickersin K, Garner E, Gaudilliere JP, Hinestrosa C, Hubbard R, Johnson PA, Missmer SA, Norsigian J, Pearson C, Rosenberg CE, Rosenberg L, Rosenkrantz BG, Seaman B, Sonnenschein C, Soto AM, Thornton J, Weisz G. Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives.

J Epidemiol Community Health. 59(9):740-8, 2005.

2. Wieland S, Dickersin K. Selective outcome reporting and indexing limit MEDLINE search sensitivity for observational studies of adverse effects. J Clin Epidemiol 2005 58(6):560-7, 2005.

3. Tumber MB, Dickersin K. Publication of clinical trials: Accountability and accessibility. J Intern Med 256:271-83, 2004.

4. Dickersin K, Munro M, Langenberg P, Scherer R, Frick K, Weber A, Johns A, Peipert J, Clark M, and the STOP-DUB Research Group. Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB): Design and methods. Controlled Clin Trials 24:294-305, 2003.

5. Dickersin K, Rennie D. Registering clinical trials. JAMA 290:516-523, 2003.

6. Feldon S, Scherer R, Hooper F, Kelman S, Baker RS, Granadier RJ, Kosmorsky GS, Seiff SR, Dickersin K for the Ischemic Optic Neuropathy Decompression Trial Research Group. Surgical quality assurance in the Ischemic Optic Neuropathy Decompression Trial (IONDT). Controlled Clin Trials. 24:294-305, 2003.

7. Scherer R, Zhu Q, Langenberg P, Feldon S, Kelman S, Dickersin K for the Ischemic Optic Neuropathy Decompression Trial Research Group. Comparison of information obtained by operative note abstraction to that recorded on a standardized data collection form. Surgery 133:324-30, 2003.

8. Dickersin K. Systematic reviews in epidemiology: Why are we so far behind? Int J Epidemiol 31:6-12, 2002.

9. Dickersin K, Olson CM, Rennie D, Cook D, Flanagin A, Zhu Q, Reiling J, Pace B. Association between time interval to publication and statistical significance: Reports of controlled trials published in JAMA. JAMA 287:2829-2831, 2002.

10. Dickersin K, Manheimer E, Wieland LS, Robinson KA, Lefebvre C, McDonald S and the CENTRAL Development Group. Development of The Cochrane Collaboration’s CENTRAL Register of Controlled Clinical Trials. Eval Health Professions 25:38-64, 2002.

11. Robinson K, Dickersin K. Development of a highly sensitive search strategy for the retrieval of controlled trials using PubMed. Int J Epidemiol 31:150-153, 2002.

12. Dickersin K. Systematic reviews in epidemiology: Why are we so far behind? Int J Epidemiol 31:6-12, 2002.

13. Andejeski Y, Bisceglio IT, Dickersin K , Johnson JE, Robinson SI, Smith HS, Visco FM, Rich I. Quantitative impact of including consumers in the scientific review of breast cancer research proposals. J Womens Health Gender Based Med 11:379-388, 2002.

14. Olson CM, Rennie D, Cook D, Dickersin K, Flanagin A, Hogan J, Zhu Q, Reiling J, Pace B. Publication bias in editorial decision making. Assessment of reports of controlled trials. JAMA 287:2825-2828, 2002.

15. Dickersin K, Olson CM, Rennie D, Cook D, Flanagin A, Zhu Q, Reiling J, Pace B. Association between time interval to publication and statistical significance: Reports of controlled trials published in JAMA. JAMA 287:2829-2831, 2002.

16. Dickersin K, Scherer R, Suci EST, Gil-Montero M. Problems with indexing and citation of articles with group authorship. JAMA 287:2772-2774, 2002.

17. Newman N, Scherer RS, Langenberg P, Kelman SE, Kaufman D, Feldon S, Dickersin K for the Ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in NAION: Report from the Ischemic Optic Neuropathy Decompression Trial Followup Study. Am J Ophthalmol 134:317-328, 2002.